Schering-Plough 2Q Revenues: $4.9 billion (+55%) 2Q Earnings: $436 million (-16%) YTD Revenues: $9.6 billion (+56%) YTD Earnings: $726 million (-34%) Comments: Pharmaceutical sales were $3.7 billion in the quarter (+47%) and $7.3 billion YTD (+48%) driven by Remicade sales ($557 million in the quarter, up 41% and $1.1 billion YTD, up 39%). Nasonex sales were $311 million in the quarter (+6%) and $618 million YTD (+7%). Temodar sales were $251 in the quarter (+16%) and $487 million...